Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Critical Care Medicine|May 30, 2001
Safety of human albumin based on spontaneously reported serious adverse eventsI von Hoegen, C WallerProceedings of the National Academy of Sciences of the United States of America|February 1, 1989
Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientationE Nakayama, I von Hoegen, J R ParnesJournal of Immunology (Baltimore, Md. : 1950)|June 15, 1990
Identification of a human protein homologous to the mouse Lyb-2 B cell differentiation antigen and sequence of the corresponding cDNAI Von Hoegen, E Nakayama, J R ParnesEuropean Journal of Immunology|February 1, 1989
Internalization of interleukin 1 (IL 1) correlates with IL 1-induced IL 2 receptor expression and IL 2 secretion of EL4 thymoma cellsI Von Hoegen, W Falk, G Kojouharoff, et al.Gene|September 7, 2000
Stabilized, long-term expression of heterodimeric proteins from tricistronic mRNAC Mielke, M Tümmler, D Schübeler, et al.Cytokine|March 1, 1996
A fusion protein of IL-8 and a Fab antibody fragments binds to IL-8 receptors and induces neutrophil activationW Holzer, F Petersen, W Strittmatter, et al.European Journal of Immunology|June 1, 1991
Identity of human Lyb-2 and CD72 and localization of the gene to chromosome 9I Von Hoegen, C L Hsieh, R Scharting, et al.Nature|June 20, 1991
The B-cell surface protein CD72/Lyb-2 is the ligand for CD5H Van de Velde, I von Hoegen, W Luo, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1992
Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72)W Luo, H Van de Velde, I von Hoegen, et al.American Journal of Hematology|November 1, 1992
Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemiasR Schwarting, R Castello, G Moldenhauer, et al.Pageof 2